From: The role of colchicine in the management of COVID-19: a Meta-analysis
Study | Type of study | Relative Risk | 95% CI | P-value |
---|---|---|---|---|
Recovery Collaborative Group 2021 | RCT | 0.98 | 0.94–1.03 | 0·44 |
Sandhu et al. 2020 | NRCT | 4.76 | 1.96–11.11 | 0.00032 |
Brunetti et al. 2020 | Cohort | 5.0 | 1.25–20.08 | 0.023 |
Fixed Effect Model | 0.99 | 0.12–7.85 | – |